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Abstract 
Background: Dietary flavonoid intake and intake of flavonoid subclasses has been associated with 
improved cognitive performance. However, the association between flavonoid intake and cognitive 
performance in older adults with Alzheimer's type dementia has not been investigated. Objectives: To 
estimate dietary total flavonoid intake and intake of flavonoid subclasses in older adults with Alzheimer's 
type dementia and assess the relationship of flavonoid intake with measures of cognition. Design: Cross 
sectional analysis. Setting: Community dwelling older adults in NSW, Australia. Participants: Older adults 
(+65y) with mild to moderate dementia (n=49). Measurements: A 24h diet recall was collected with help 
from a carer and used to estimate flavonoid intake. A battery of cognitive tasks assessed cognitive 
performance of several cognitive domains. Results: Pearson and spearman correlation coefficients 
identified an association between flavonoid intake and executive function (r=0.319, p=0.025). After 
controlling for depression, the relationship was reduced. Conclusion: The identified association between 
cognitive functioning, depression and flavonoid intake in older adults with Alzheimer's type dementia 
warrants further research in a larger sample. 
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DIETARY FLAVONOID INTAKE AND COGNITIVE 
PERFORMANCE IN OLDER ADULTS  
WITH ALZHEIMER’S TYPE DEMENTIA
K. Kent1, S. Roodenrys2, K.E. Charlton1, R. Richards2, O. Morgan2, H. Gilbert2
Introduction 
Flavonoids are naturally occurring plant-based 
phytochemicals, which are abundant in the human 
diet. The structure and sources of flavonoids has been 
well established (1, 2).  Flavonoids are a subclass of 
polyphenols and encompass a wide group of compounds 
that are divided into six major classes: anthocyanidins, 
flavanols, flavanones, flavones, flavonols and isoflavones 
(1). A growing body of evidence suggests that flavonoids 
are non-nutritive bioactive compounds, which 
significantly contribute to the antioxidant activity of 
individual fruits and vegetables and are consequently 
credited with the observed health benefits (3). Flavonoids 
are widespread across many food sources and are 
found in particularly high concentrations in fruits 
and vegetables, wine, tea, cocoa, and soy (4). In older 
Australian adults, major dietary sources of flavan-3-
ols and flavonols are tea (black and green) and apples; 
flavanones are provided by citrus fruits and juices; 
flavones are consumed through parsley and tomatoes; 
and berries and red wine provide anthocyanins (5). 
Isoflavones are largely provided by the consumption of 
soy-based products (6).  
Total dietary flavonoid consumption has been 
association with improved cognitive performance and 
a preservation of cognitive function with ageing (7-9). 
More focussed research on specific flavonoid subclasses 
has revealed that the sub-groups flavanols, anthocyanins 
and flavanones may provide the most beneficial effects 
in the area of neuroprotection (10). There has been a 
particular focus in animal models, on the provision 
of anthocyanin rich foods, such as blueberries, when 
investigating cognitive outcomes, with promising results 
(11-13). Preliminary human trials have also begun to link 
anthocyanin-rich food consumption with improvements 
in cognitive outcomes (14-18).  A high consumption 
of total dietary flavonoids has also been linked with a 
reduced risk of developing a neurodegenerative disease, 
such as dementia (19). However, the association between 
flavonoid intake and cognitive performance in older 
adults with Alzheimer’s type dementia has not been 
investigated to date.
The mechanisms by which flavonoids provide 
neuroprotection are not well elucidated and the 
evidence remains largely pre-clinical. This is partially 
related to the quick and extensive metabolism of dietary 
flavonoids into metabolites with differing and largely 
unknown biological activities (1). In animal models, 
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specific flavonoids including the flavanols catechin 
and epigallocatechin gallate (20) have been shown to 
reduce neuroinflammation and scavenge free radicals 
within the brain (2), a function which has been related to 
neuroprotection. Additionally, flavonoids, including the 
flavanone hesperitin have been shown to provide a range 
of positive neuronal effects to limit neurodegeneration, 
including a potential to protect neurons against injury 
and improve neuronal morphology (2, 21). Flavonoid 
supplementation has also been shown to up-regulate 
processes that promote learning, memory and cognition 
(1). Flavonol-rich cocoa consumption has shown to 
increase cerebrovascular blood flow, which is associated 
with improved cognition (22). Presently, it is unclear how 
many, or if all flavonoids exert such effects (1). 
Evidence is mounting for the positive protective 
effects of flavonoid consumption for the development 
of dementia (7, 19, 23), including consumption of 
flavonoid rich fruits and vegetables, juices and wine 
(24, 25). However, it is also important to investigate the 
relationship between flavonoid consumption in older 
adults living with dementia and cognitive performance 
outcomes. This evidence could be utilized to indicate if 
dietary interventions with flavonoids may be warranted. 
It is well documented that older adults with dementia 
develop eating difficulties, resulting in low food 
intake, as dementia progresses (26). This can be related 
to a myriad of difficulties including dysphasia, lack of 
appetite, confusion about the need to eat and the loss 
of the ability to recognize food (27). The total dietary 
intake and significant sources of dietary flavonoids in 
older adults living with dementia has not been assessed 
and may differ from estimations for healthy adults aged 
65+yrs. 
The aim of this study was to estimate the total dietary 
intake and main sources of flavonoids in older Australian 
adults with Alzheimer’s type dementia and to assess 
the relationship between dietary flavonoid intake and 
cognitive performance.
 
Methods
This study was approved by the University of 
Wollongong and Illawarra Shoalhaven Local Health 
District Human Research Ethics Committee (HE11/175) 
and complied with current laws governing ethics in 
research. The current study analysed the baseline data 
of a randomised controlled trial, which investigated the 
impact of anthocyanin-rich cherry juice on cognitive 
outcomes in older adults with dementia (17) 
Community dwelling older adults (65+yrs) with mild 
to moderate Alzheimer’s type dementia (as diagnosed 
by a hospital-based geriatrician) were recruited to 
the study from an outpatient clinic. Dietary data was 
collected by a trained nutritionist (KK) (with assistance 
and confirmation provided from a carer) from a single 
24-h food recall. The dietary data was analysed using 
the Foodworks dietary analysis package (Xyris software, 
version 5, 2007, Highgate Hill, QLD, Australia) (28). As 
dietary data relating to flavonoid content of foods is not 
integrated into the Xyris software, the food items were 
manually cross-referenced with the USDA database for 
the flavonoid content of selected foods (release 3.1) (29) to 
estimate total flavonoid consumption and the flavonoid 
subclasses anthocyanins, flavones, flavanones, flavonols 
and flavan-3-ols. A Mini Nutritional Assessment (30) 
was conducted as a measure of malnutrition and 
Lawton’s Instrumental Activities of Daily Living Scale 
(31) measured functional ability. Anthropometric and 
demographic information, including education, was 
collected (Table 1), with assistance from a guardian or 
carer as appropriate. 
A battery of cognitive assessments was administered 
by a single trained researcher (KK). These included 
measures of mood (32), verbal learning and memory (33), 
working memory (34), semantic memory (35), executive 
function (36, 37) and short-term memory (38) (Table 2). 
To assess the relationship between flavonoid intake 
and cognitive performance, bivariate correlations with 
Pearson and Spearman coefficients (as appropriate) 
were performed and then repeated after controlling for 
depression, as measured by the Geriatric Depression 
Scale (GDS) (32). Multiple regression analysis was 
performed to confirm the effect of flavonoid intake on 
cognitive outcomes that were identified as significant by 
the correlations, with age and education included in the 
models as covariates.
 
Results
Forty-nine participants volunteered to take part 
in the study; their anthropometric and demographic 
characteristics are found in Table 1. 
Figure 1
Percentage contribution of flavonoid subclasses to total 
flavonoid intake
Analysis of the 24h dietary recall calculated total 
flavonoid intake to be 510.2 ± 374.8mg/day, with a 
range of 5.9 – 1,524.2 mg/day. Black tea contributed 
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80% of total dietary intake and was the most notable 
dietary source of flavonoids. Other notable sources 
were green tea (7.5%), red wine (4.5%), with apples and 
oranges providing 1.7% and 1.6% respectively, when 
combined with their fruit juices. The dominant subclass 
of flavonoids was flavan-3-ols; these contributed 88% of 
total intake (Figure 1). 
Total flavonoid intake was not significantly correlated 
with age, nutritional status or education. However, 
participants who displayed greater depressive symptoms 
(i.e. scored higher on the GDS) had a lower total 
flavonoid intake (r=-0.328 p=0.021). 
Total flavonoid intake was significantly correlated 
with verbal fluency (r=0.319 p=0.025) (Table 2). 
Verbal fluency was also significantly correlated with 
the flavonoid subclasses flavonols (r=0.321 p=0.025), 
flavan-3-ols (r=0.323 p=0.023) and anthocyanins 
(r=0.298, p=0.038). No other significant associations 
were identified. A regression analysis was conducted to 
predict verbal fluency from total flavonoid intake, with 
age and education as covariates. Total flavonoid intake 
statistically significantly predicted verbal fluency score 
(β =0.319, p=0.025) controlling for age (β=0.042, p=0.765) 
and education (β=0.219, p=0.124). The overall model fit 
was r2=0.148. 
After controlling for depression (GDS continuous 
score), bivariate correlations showed no significant 
relationship between total flavonoid intake or flavonoid 
subclasses was shown (Table 2).
 
Discussion
The mean intake of total flavonoids (510mg/day) 
in this sample of older adults with mild to moderate 
Alzheimer’s type dementia is lower than the other 
estimations in older Australian adults, which were 
683mg/day (5) (from 12 day food records) and 575mg/
day (from a single 24h dietary recall) (39). However, 
the major dietary sources and percentage contributions 
from each flavonoid subclass are similar (5, 39). Black 
tea was the major dietary source of flavonoids (80%), 
and this finding highlights a limited fruit and vegetable 
consumption in this group.
The relationship between cognitive performance on 
Table 1
Characteristics of study participants (n=49)
Age (years) 79.82 ± 6.9
Gender
  Male 24
  Female 25
BMI (kg/m2) 26.1 ± 3.5
Current smokers (%) 2.7%
Previous smokers (%) 40.5%
Hand grip strength (kg) 33.2 ± 6.9
Mid arm circumference (cm) 27.1 ± 4.2
Calf circumference (cm) 34.1 ± 3.6
Education  (count)
  Primary 3
  Secondary (year 10) 24
  Secondary (year 12) 10
  Tertiary 12
Mini Nutritional Assessment 24.2 ± 3.1
Lawton’s Instrumental Activities of Daily Living Scale 6.2 ± 2.3
Ideal BMI for adults 65y+ is 22–27 kg/m2 (13); Calf circumference and mean 
mid-upper arm circumference in of 29.2 in older adults; Mini Nutritional As-
sessment score >23.5 indicates no risk of malnutrition (14); Median maximum 
hand grip strength are 37.9 kg and 31.5 kg for men and women aged 50y+ (15); 
Lawton’s IADL scale mean score 4.3 in adults with moderate dementia (11).
Table 2
Cognitive instruments, domain targeted and relationship with total flavonoid intake
Cognitive Instrument Domain Bivariate relationship  total 
flavonoid intake
Bivariate relationship total 
flavonoid intake controlling for 
depression (GDS)
The Geriatric Depression scale (12) Mood r=-0.367, p=0.009 ** -
Rey Auditory Verbal Learning 
Test (16)
Verbal learning and memory r=0.161, p=0.270 r=102, p=0.439
Self Ordered Pointing Task (17) Working memory r=-0.095, p=0.588 r=-0.046, p=0.760
The Boston Naming Task (18) Semantic memory r=0.095, p=0.514 r=-0.019, 0.899
The Verbal Fluency Task (19) Executive function and control 
processes
r=0.319, p=0.025 * r=0.191, p=0.198
Trail Making Task (20) Executive function r=-0.98, p=0.504 r=-0.051, p=0.773
Digit Span Backwards Task (21) Short-term memory storage and 
executive control
r=0.047, p=0.747 r=-0.005, p=0.972
* Correlation is sig. at p<0.05. ** Correlation is sig. at p<0.01
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the verbal fluency task (a measure of executive function), 
and flavonoid intake is supported by literature which 
suggests that executive function can be positively 
influenced by flavonoid supplementation and habitual 
flavonoid intake (40). The relationship between verbal 
fluency and intake of the flavonoid subclasses flavonols, 
flavan-3-ols and anthocyanins (but not flavanones, or 
flavones) may be related to the consumption of  black 
and green tea (the major sources of flavonols and flavan-
3-ols) and berries (a major source of anthocyanins), in 
this group. The consumption of both green and black 
tea has been associated with improved cognition in 
older adults (41), although a recent systematic review 
considered the role of tea in mild-cognitive impairment 
and dementia progression and reported that the findings 
were too limited to draw conclusions (42).  Similarly, 
the consumption of anthocyanin rich strawberries and 
blueberries has been associated slower cognitive decline 
(43).
The lack of correlation between total flavonoid intake 
and education, nutritional status and age indicates that in 
this cohort these factors do not impact on total flavonoid 
consumption. This may be explained by tea consumption, 
the largest contributor to total flavonoid intake being a 
universally consumed item by all socioeconomic groups, 
and also reflects the lack of energy or micronutrients 
provided by this beverage, thus not impacting on 
nutritional status.
The positive association between depressive 
symptomatology (as measured by GDS) and flavonoid 
intake (r=-0.367, p=0.009) is interesting. The reduction 
in association between verbal fluency and flavonoid 
intake when depression was included as a covariate 
suggests that this relationship is confounded by 
the effect of depression on executive functioning. We 
speculate that epidemiological studies that have reported 
associations between flavonoid intake and cognitive 
outcomes, without controlling for depression, may have 
overestimated the strength of this relationship (7).
There is little consensus regarding which cognitive 
domain is impacted by flavonoid intake (40, 44) or which 
tool should be employed to measure this effect (44). 
We therefore used a battery of cognitive tests in order 
to investigate a wide range of domains of cognitive 
function, ensuring that each of the validated tests was 
sensitive and specific. Generalizability of the study 
findings is limited by the small sample size and the 
non representative nature of the convenience study 
sample. Other limitations include the inadequacy of 
using a single 24h dietary recall to estimate habitual 
dietary flavonoid intake. Aside from the limitations 
associated with this dietary assessment method, there 
are several well documented problems associated 
with utilising food composition databases to assign 
flavonoid content to selected foods to reflect dietary 
intake. These limitations include an incomplete list of 
flavonoid containing foods, non-regional specific data 
(there is no Australian database for the flavonoid content 
of foods comprising the Australian food supply), and 
the inability of a dietary assessment to account for the 
high intra-individual variation of flavonoid absorption 
and metabolism (45). These limitations may result large 
variations in estimations of flavonoid intake (6) that differ 
from the true value, and may hinder our interpretation of 
observational data that associates flavonoid intake with 
specific health outcomes. 
In conclusion, dietary intake of flavonoids in a sample 
of older adults with Alzheimer’s disease was found to be 
somewhat lower than current Australian estimations for 
this age group, but the contributions of dietary sources 
are similar to the general older population. The identified 
association between cognitive functioning, depression 
and flavonoid intake in older adults with Alzheimer’s 
type dementia warrants further research in a larger 
sample to confirm the findings and to identify whether 
dietary interventions may be indicated.
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